share_log

Ultragenyx Pharmaceutical | 8-K: Ultragenyx Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Update

SEC announcement ·  Feb 15 16:09
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more